--- title: FidoCure blog | Christina K. Lopes description: Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates. --- [![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/fidocure_logo.png?width=296&height=68&name=fidocure_logo.png "FidoCure")](https://www.fidocure.com/) - [Veterinarians](https://fidocure.com/for-veterinarians/) - [Portal Login](https://dvm.fidocure.com/) - [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet) - [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies) - [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars) - [Pet Parents](https://fidocure.com/pet-parents/) - [About Us](https://fidocure.com/about-us/) - [How it works](https://fidocure.com/how-it-works/) - [Find a Clinic](https://fidocure.com/find-a-clinic/) - [Contact Us](https://fidocure.com/contact-us/) # FidoCure Veterinary Team Blog ### Read the latest in veterinary oncology research and FidoCure scientific and clinical updates from our team of experts and advisors Select Category Case Studies Press Vet Webinars This is a search field with an auto-suggest feature attached. - There are no suggestions because the search field is empty. Posts by: ## Christina K. Lopes ![](https://blog.fidocure.com/hubfs/Template%20Blog%20Sized%20%20(2).png) ### [Global Impact from the U.S. to Korea at FAVA 2024](https://blog.fidocure.com/fidocure-blog/fava) We are excited to share that Dr. Lucas Rodrigues, FidoCure's Head of Veterinary Research, will be presenting twice at the [23rd Federation of Asian Veterinary Associations (FAVA) Congress](https://www.fava2024.org/sub01/welcome.html), taking place from October 25 to October 27, 2024. This event marks an important opportunity for us to engage with veterinary professionals from around the world and contribute to the ongoing dialogue about canine cancer treatment. [Read More](https://blog.fidocure.com/fidocure-blog/fava) ![](https://blog.fidocure.com/hubfs/Blog_VetTechWeek.png) ### [FidoCure Celebrates National Veterinary Technician Week](https://blog.fidocure.com/fidocure-blog/vettechweekgiveaway) As National Veterinary Technician Week (October 13-19) approaches, FidoCure is proud to celebrate the vital role vet techs play in supporting pets and their families in the fight against cancer. [Read More](https://blog.fidocure.com/fidocure-blog/vettechweekgiveaway) ![](https://blog.fidocure.com/hubfs/FC_DD_X.png) ### [FidoCure Celebrates National Dog Day](https://blog.fidocure.com/fidocure-blog/fidocure-celebrates-national-dog-day) Happy National Dog Day from all of us at FidoCure! Today, we celebrate the joy, companionship, and unconditional love that dogs bring into our lives. At FidoCure, our mission is to ensure that these beloved companions live longer, happier, and healthier lives, even when faced with the challenge of cancer. [Read More](https://blog.fidocure.com/fidocure-blog/fidocure-celebrates-national-dog-day) ![](https://blog.fidocure.com/hubfs/Blog_ChristinaForbes.png) ### [Forbes Interview: FidoCure CEO Thinks Drugs For Dogs Can Help Humans Fight Cancer](https://blog.fidocure.com/fidocure-blog/forbes-interview) [Read More](https://blog.fidocure.com/fidocure-blog/forbes-interview) ![](https://blog.fidocure.com/hubfs/FC_KC_X.png) ### [FidoCure CEO Christina Lopes to Showcase World's First Portfolio of Canine Cancer Drugs at 2024 Animal Health Summit](https://blog.fidocure.com/fidocure-blog/fidocure-ceo-christina-lopes-to-showcase-worlds-only-portfolio-of-canine-cancer-drugs-at-2024-animal-health-summit) FidoCure CEO Christina Lopes will present at the 2024 Animal Health Summit in Kansas City on August 26-27. The summit will showcase emerging companies and foster connections between innovators, investors, and industry leaders in animal health, nutrition, and technology. Attendees can also expect 1:1 business partnering opportunities, interactive experiences, and presentations from some of the world's leading minds in the field. [Read More](https://blog.fidocure.com/fidocure-blog/fidocure-ceo-christina-lopes-to-showcase-worlds-only-portfolio-of-canine-cancer-drugs-at-2024-animal-health-summit) ![](https://blog.fidocure.com/hubfs/fc_round3-02.png) ### [FidoCure Secures Patent for AI-Driven Precision Medicine](https://blog.fidocure.com/fidocure-blog/fidocure-secures-patent-for-ai-driven-precision-medicine) **FidoCure to Transform the Precision Medicine Landscape with New Patent, Accelerating Drug Development for Dogs with Cancer** [Read More](https://blog.fidocure.com/fidocure-blog/fidocure-secures-patent-for-ai-driven-precision-medicine) ![](https://blog.fidocure.com/hubfs/Cancer%20Type%20Blog%20Sized%20%20(1)-1.png) ### [Vet Optimist Podcast: Interview with CEO Christina K. Lopes and Jennifer Evans](https://blog.fidocure.com/fidocure-blog/veterinaryoptimistpodcast) We are excited to share an inspiring and insightful episode of "The Veterinary Optimist" podcast, featuring our very own Christina Lopes, CEO and Co-Founder of The One Health Company. In this special episode, Christina opens up about her journey, from her father’s battle with cancer to the loss of several beloved family dogs, and how these experiences fueled her passion for revolutionizing cancer treatment for pets. Christina also delves into her background working with marginalized communities, which inspired her to focus on helping voiceless beings and ultimately led her to the veterinary field. Under her leadership, FidoCure has made remarkable strides, expanding into over 1,350 veterinary clinics and treating more than 5,000 dogs with innovative AI and genomic sequencing technologies. We invite you to listen to Christina's story and learn more about our mission to improve the lives of dogs and their families with cancer. [Tune in to the podcast on Apple Podcasts,](https://podcasts.apple.com/us/podcast/how-fidocure-is-helping-dogs-with-cancer-with/id1693006394?i=1000661883920)and don’t forget to check out the full transcription of the episode below. Thank you for being a part of the FidoCure community and supporting our mission to help over 1 million dogs live healthier, happier lives--and ultimately fight cancer on both ends of the leash. [Read More](https://blog.fidocure.com/fidocure-blog/veterinaryoptimistpodcast) ![](https://blog.fidocure.com/hubfs/Screenshot%202024-07-09%20at%2010.51.06%20AM.png) ### [Companion Animal Science Takes Center Stage: Insights from The New York Times](https://blog.fidocure.com/fidocure-blog/companion-animal-science-takes-center-stage-insights-from-the-new-york-times) A recent article in [*The New York Times*](https://www.nytimes.com/2024/06/30/science/pets-research-dogs-cats.html), titled, "How science went to the dogs (and cats)," highlights the remarkable evolution of companion animal research over the past two decades. Once dismissed as trivial subjects, pets are now at the forefront of scientific inquiry, with researchers around the world delving deep into the bodies and minds of cats and dogs. [Read More](https://blog.fidocure.com/fidocure-blog/companion-animal-science-takes-center-stage-insights-from-the-new-york-times) ![](https://blog.fidocure.com/hubfs/Hubspot%20Blog%20Sized%202%20(6).png) ### [Small Molecules, Big Impact: An Interview with Dr. Cheryl London](https://blog.fidocure.com/fidocure-blog/small-molecules-big-impact-an-interview-with-dr.-cheryl-london) ###### *Explore the history and impact of small molecules in this fascinating discussion. FidoCure’s Chief Medical Officer, Dr. Gerry Post interviews Dr. Cheryl London about their application in canine cancer treatment.* Dr. Cheryl London is a world-renowned expert in veterinary oncology and targeted cancer therapies at Tufts University. Her pioneering work began in 2000 when she collaborated with SUGEN to develop Palladia, one of the first targeted small molecule drugs approved for veterinary use, treating canine mast cell tumors driven by KIT mutations.  [Read More](https://blog.fidocure.com/fidocure-blog/small-molecules-big-impact-an-interview-with-dr.-cheryl-london) ![](https://blog.fidocure.com/hubfs/Twitter%20banner%205000%20cases%20(1).png) ### [We've Reached 5000 Patients!](https://blog.fidocure.com/fidocure-blog/weve-reached-5000-cases) We are thrilled to share with you an incredible milestone in our journey to revolutionize canine cancer treatment. Thanks to your unwavering support and dedication, we have now enrolled over **5,000 dogs** in the FidoCure platform! This achievement is a testament to the trust you have placed in our innovative approach and the positive impact we are making together in the lives of dogs and their families. [Read More](https://blog.fidocure.com/fidocure-blog/weve-reached-5000-cases) [1](https://blog.fidocure.com/fidocure-blog/author/christina-k-lopes) [2](https://blog.fidocure.com/fidocure-blog/author/christina-k-lopes/page/2) [3](https://blog.fidocure.com/fidocure-blog/author/christina-k-lopes/page/3) ![fc_portal_logo_bw](https://blog.fidocure.com/hubfs/fc_portal_logo_bw.svg) - [How it Works](https://fidocure.com/how-it-works/) - [FAQ](https://fidocure.com/faq/) - [Contact Us](https://fidocurestg.wpengine.com/contact-us/) - [For Vets](https://fidocure.com/for-veterinarians/) - [About Us](https://fidocure.com/about-us/) - [Terms of Service](https://fidocure.com/terms-of-service/) - [Blog](https://blog.fidocure.com/fidocure-blog) - [Careers](https://fidocure.com/careers/) - [Privacy Policy](https://fidocure.com/privacy-policy/) - - - - **FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy.  © Copyright 2018-2026 One Health Company, All rights reserved